Volume 19, Issue 3 , Pages 225-227, May 2008
Case Presentation: Nephrolithiasis in a Patient Treated With Atazanavir
Of the recently approved antiretroviral protease inhibitors, atazanavir has become a popular medication for the treatment of HIV infection. The advantages of an atazanavir-based regimen include a favorable side effect profile, low impact on lipids, low pill burden, and daily dosing. These have made it a favorable choice for antiretroviral treatment. As more experience is gained with newer antiretroviral medications, additional side effects become apparent. Recent reports have highlighted occurrences of nephrolithiasis in patients using atazanavir-based regimens. The authors present a case of a patient who experienced nephrolithiasis while taking combination antiretroviral therapy that included atazanavir.
Key words: ART, atazanavir, nephrolithiasis, renal colic, urolithiasis
To access this article, please choose from the options below
PII: S1055-3290(08)00043-5
doi:10.1016/j.jana.2007.11.005
© 2008 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.
Volume 19, Issue 3 , Pages 225-227, May 2008
